article thumbnail

What's Market: Alternative Dispute Resolution Provisions

JD Supra: Mergers

arbitration or mediation). In M&A purchase agreements, the parties may stipulate certain non-judicial means for dealing with claims under the agreement (e.g., These ADR provisions will govern how disputes between the parties are to be handled. Originally Published in Bloomberg Law. By: Goulston & Storrs PC

Mediation 167
article thumbnail

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Global Newswire by Notified: M&A

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Company Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

Global Newswire by Notified: M&A

(Nasdaq: BIIB) and Human Immunology Biosciences (HI-Bioâ„¢), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15

article thumbnail

Biogen Completes Acquisition of Human Immunology Biosciences

Global Newswire by Notified: M&A

(Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bioâ„¢), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs).

article thumbnail

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Global Newswire by Notified: M&A

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have.

article thumbnail

10 ways to handle a workplace conflict

Growth Business

> See also: Managing workplace conflict: Are you ready to mediate? Act as a mediator If you are not directly involved in a work-related conflict, but still find yourself at the centre of it, acting as a mediator can help control the situation and prevent any further escalations.

article thumbnail

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Global Newswire by Notified: M&A

Topline data from Phase 3 ONWARD trials for Alumis ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026